NASDAQ : CABR
Caring Brands, Inc. — Key statistics
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 1.07 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 11.09M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 11.72M |
| Enterprise Value | 9.90M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 18, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 10.37M |
| Shares Outstanding | 10.37M |
| Shares Change (YoY) | -4.18% |
| Shares Change (QoQ) | -37.74% |
| Owned by Insiders (%) | 13.50% |
| Owned by Institutions (%) | 1.52% |
| Float | 2.47M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10,108.80 |
| Forward PS | n/a |
| PB Ratio | 7.68 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 8,538.16 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 4.96 |
| Quick Ratio | 4.73 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -14.87 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -333.74% |
| Return on Assets (ROA) | -108.32% |
| Return on Invested Capital (ROIC) | -121.43% |
| Return on Capital Employed (ROCE) | -298.12% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $386 |
| Profits Per Employee | -$3.29M |
| Employee Count | 3 |
| Asset Turnover | 0.00 |
| Inventory Turnover | 0.04 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | n/a |
| 52-Week Price Change | -71.89% |
| 50-Day Moving Average | 1.22 |
| 200-Day Moving Average | 1.15 |
| Relative Strength Index (RSI) | 46.63 |
| Average Volume (20 Days) | 37,978 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 2,863 |
| Short Previous Month | 6,427 |
| Short % of Shares Out | 0.03% |
| Short % of Float | 0.12% |
| Short Ratio (days to cover) | 0.11 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1,159 |
| Gross Profit | 686 |
| Operating Income | -4.55M |
| Pretax Income | -7.73M |
| Net Income | -9.88M |
| EBITDA | -4.25M |
| EBIT | -4.55M |
| Loss Per Share | -$0.77 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 1.82M |
| Total Debt | n/a |
| Net Cash | 1.82M |
| Net Cash Per Share | $0.18 |
| Equity (Book Value) | 1.52M |
| Book Value Per Share | -0.30 |
| Working Capital | 1.52M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -2.26M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 300,000 |
| Net Borrowing | 3.99M |
| Free Cash Flow | -2.26M |
| FCF Per Share | -$0.22 |
Margins
| Measure | Value |
|---|
| Gross Margin | 59.19% |
| Operating Margin | -392,263.59% |
| Pretax Margin | -666,612.60% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 4.18% |
| Shareholder Yield | 4.18% |
| Earnings Yield | -68.39% |
| FCF Yield | -19.25% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 24.54 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |